Skip to main content
. 2010 Apr 7;5:63–69. doi: 10.2147/cia.s8883

Figure 1.

Figure 1

The cumulative risk of stroke (A) and the composite outcome of stroke, acute coronary syndrome or cardiovascular death (B). Reproduced with permission from Connolly SJ, Crijns HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation. 2009;120:1174–1180.18 Copyright © 2009 Wolters Kluwer Health.